Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

ClinicalTrials.gov ID: NCT02717195

Public ClinicalTrials.gov record NCT02717195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Study identification

NCT ID
NCT02717195
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
1,098 participants

Conditions and interventions

Conditions

Interventions

  • Risperidone Drug
  • Olanzapine Drug
  • Lu AF35700 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2016
Primary completion
Aug 29, 2018
Completion
Oct 7, 2018
Last update posted
Nov 24, 2019

2016 – 2018

United States locations

U.S. sites
49
U.S. states
14
U.S. cities
42
Facility City State ZIP Site status
US1018 Bellflower California 90706
US1041 Cerritos California 90703
US1062 Costa Mesa California 92626
US1463 Culver City California 90230
US1104 Garden Grove California 92845
US1118 Glendale California 91206
US1114 National City California 91950
US1452 Oceanside California 92056-4509
US1459 Oceanside California 92056-4515
US1399 Orange California 91945
US1368 Orange California 92868
US1391 San Bernardino California 92408-3332
US1464 Santa Ana California 92705-3610
US1384 Sherman Oaks California 91403-1747
US1392 Torrance California 90502-4432
US1396 Washington D.C. District of Columbia 20016
US1395 Bradenton Florida 32751
US1253 Jacksonville Florida 32256
US1130 Miami Florida 33122
US1318 North Miami Florida 33161
US1129 North Miami Florida 33162
US1402 Oakland Park Florida 33334-4400
US1229 Orange City Florida 32763
US1453 Tampa Florida 33609-2231
US1403 Atlanta Georgia 30328
US1009 Atlanta Georgia 30331
US1442 Decatur Georgia 30030
US1046 Chicago Illinois 60640
US1423 Hoffman Estates Illinois 60169-1067
US1398 Shreveport Louisiana 71101-4603
US1404 Shreveport Louisiana 71104-2136
US1086 Flowood Mississippi 39232
US1444 Las Vegas Nevada 89102-1943
US1426 Berlin New Jersey 08009
US1454 Marlton New Jersey 08053
US1405 Glen Oaks New York 11004
US1244 Jamaica New York 11432
US1394 New York New York 10032
US1416 New York New York 10035-6000
US1171 Rochester New York 14618
US1190 Staten Island New York 10312
US1390 Charlotte North Carolina 28204-3110
US1401 Charlotte North Carolina 28211-1064
US1441 Hickory North Carolina 28601-5045
US1124 Norristown Pennsylvania 19403
US1319 Charleston South Carolina 29407
US1451 Austin Texas 78754-5122
US1065 Dallas Texas 75243
US1443 Fort Worth Texas 76104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02717195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02717195 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →